Help us Find a Cure for
Angelman Syndrome
Welcome to the Foundation for Angelman Syndrome Therapeutics UK.
We have one goal: to cure Angelman Syndrome.
What is Angelman Syndrome?
Drug Development Pipline
It’s our job to push forward all promising Angelman syndrome (AS) programs, and to ensure that the community has a birds-eye view of the entire landscape.
Meet Bella...
Has your loved one been newly diagnosed with Angelman Syndrome?
Need support or advice?
The Latest at FAST UK
Alton Towers IAD Weekend 2026 – Celebrating 13 Years!
The 2026 Alton Towers event for International Angelman Day marked an incredible 13 years of bringing families together for a weekend of fun, connection, and celebration!

Art for Angelman 2024: Our Biggest Fundraiser of the Year
We are thrilled to share the incredible success of Art for Angelman 2024, which raised a record breaking £66,000 for FAST UK. This outstanding achievement makes it our biggest fundraiser of the year.

Global Angelman Syndrome Registry
Your family’s experience can help build understanding of Angelman syndrome and support research towards treatments and a cure.

International Angelman Day 2026 – Alton Towers Weekend
To everyone who helped make this year’s International Angelman Day Alton Towers weekend possible, thank you.

International Angelman Day 2026 – Alton Towers Weekend
To everyone who helped make this year’s International Angelman Day Alton Towers weekend possible, thank you.

Parent Blog: Our son, Hudson, is our real life Angel! …by Charlene Cooper
Our son, Hudson, is our real life Angel! Our blue eyed boy was born on 1st December 2020, eager to meet us as he came 3 weeks early. Hudson’s big sisters, Amelia and Madison were delighted with their new role as…

Announcing the Winner of Our 2024 Community Member Award
We are thrilled to reveal the winner of our Community Member Award, an initiative recognizing individuals who’ve made a significant impact within the Angelman syndrome community in the UK.
Fundraising News

Ivor’s Splashathon raises £1,926 for FAST UK

Paul completes the Sydney Marathon for FAST UK

Team FAST UK conquers Tough Mudder Yorkshire for Angelman Syndrome research
Scientific Updates

MavriX Bio announced that the FDA Rare Pediatric Disease Designation

Ionis shares update on CHAMPION Phase 3 clinical trial


MavriX Bio announced that the FDA Rare Pediatric Disease Designation

Ionis shares update on CHAMPION Phase 3 clinical trial

FAST Global
This website is operated by FAST UK, an independent entity organised and existing under the laws of (England and Wales). While FAST UK uses the branding of the Foundation for Angelman Syndrome Therapeutics, FAST UK is a separate and distinct entity, operating under its own governance.
At FAST UK, we’re dedicated to keeping our community informed about advancements in Angelman syndrome treatments. We’ve provided a link to the global FAST site, where you can explore an up to date overview of the drug development pipeline. This resource highlights the progress of various programs, some of which are supported by FAST and others disclosed by external organisations.
Click below to gain insight into the promising developments bringing us closer to effective treatments and, ultimately, a cure.
Prof Art Beaudet
There are many disorders that will not be cured or treated in our lifetime, but Angelman Syndrome will not be one of them.
